Search

BiomX, which customizes phages against microbiome disease-associated bacteria, has entered a collaboration with Boehringer Ingelheim. Their goal is to discover microbiome-based biomarkers for inflammatory bowel disease.

This week, we're highlighting the three feature articles we published in August: two interviews and a recap of the two PHAVES events we hosted this month. Enjoy! In place of a feature article this week, we're highlighting the three Capsid &

EMD Millipore Corporation (Bedford, Massachusetts) is hiring a Scientist III to design and execute virology testing and research projects, focused on viral (including phage) clearance and viral inactivation for biotherapeutic processing.

Dupont (Madison, Wisconsin) is hiring a Scientist to study lactic acid bacterial strains with the objective of developing new and improved starter cultures and food ingredients (competencies in understanding and managing phage in relation t

Two PhD student positions are open at KU Leuven in Belgium to unravel the role of protein acetylation in the interplay between phages and Pseudomonas bacteria. The project combines elements of research between the research groups of Prof. v

IPATH at UCSD is hiring two postdocs to work in the Pride Lab on translational projects relating to phage therapy.

The DNA Core at Delaware State University (Dover, Delaware) is hiring a Research Technician to study microbiomes, phages and phage application using molecular biological techniques and bioinformatics.

A biotechnology company in Orkney, Scotland is hiring a Laboratory Scientist to isolate phages and determine their specificity against various strains of bacteria.

Sentinel Environmental (Houston, Texas) is hiring a Research Scientist to develop novel microbiome engineering products (candidates that have experience working with phages are particularly encouraged to apply).

We're excited to announce that we've been awarded a grant from the Mozilla Foundation in partnership with Phages for Global Health (PGH), a nonprofit organization that facilitates the application of antibacterial phage technology in the dev

The Indian ‘Society for Bacteriophage Research and Therapy’ (SBRT) is a platform for phage researchers to share their expertise & resources. SBRT is pleased to announce a webinar on “Phage Directory: Making the world's phages accessible, ma

The next rendition of PHAVES will be a seminar with Dr. Sabrina Green, PhD on Sep 1 at 6 PM EST (GMT-4), 8 AM Sept 2 AEST. (Now at an Australia/NZ-friendly time!) Sabrina will give a short talk called TAILORing Phage Therapy for the Gut an

The organizers of VoM 2020, in collaboration with ISVM and Phage Directory, are excited to announce iVoM, a series of online lectures from prominent researchers studying viruses of microbes. These events will run monthly from September to F

The next (and last) KITP Bacteriophage Forum Zoom session will be Sept 1 at noon Pacific time: Dr. Britt Koskella (UCB) will present on "Phages as drivers of bacterial diversity" followed by a general discussion session.

I am an enthusiastic beginner of phage research and a PhD holder in virus immunodiagnostics. Since phage research is quite new in my country, Kenya, I am looking for mentorship from a senior phage researcher and placement in an active phage

The Cystic Fibrosis Foundation has awarded $15 Million to 33 organizations studying how to improve outcomes for cystic fibrosis patients battling infections, and three are phage therapy-based approaches! One is for research into phages that

Patrick de Jonge (Utrecht University, Netherlands) and colleagues published a new paper in iScience on AdsorpSeq, a new method for rapidly linking phages with hosts, which is based on sequencing phages physicially bound to host cell envelop

Cyclic-oligonucleotide-based anti-phage signalling systems (CBASS) share ancestry with an innate immune pathway in animals. Adi Millman (Weizmann Institute of Science, Israel) and colleagues published a new paper in Nature Microbiology on C

Clay Crippen (University of Georgia) and colleagues published a new paper in Frontiers in Microbiology showing that phages can lead multidrug resistant Acinetobacter isolates to release intact antimicrobial resistance determinants in vitro.

Moran Meir (Tel Aviv University, Israel) and colleagues published a new paper in Science Advances showing that competition between social cheater viruses is driven by mechanistically different cheating strategies.